Publication | Open Access

Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents

Medicinal ChemistryMedicinePharmacologyRational Drug DesignPharmacological AgentPharmacotherapyAnti-cancer AgentEgfr Tk InhibitorsDrug DevelopmentMolecular DockingRadiation OncologyThiazolyl-pyrazoline DerivativesDrug Discovery